So far in 2024, Camber has introduced 30 new generic products, significantly enhancing options for patients and healthcare providers. With plans to launch 36 products by the end of the year, Camber continues to lead the charge in providing cost-effective solutions that empower healthier communities across the nation.
- Avanafil Tablets
- Ketorolac Injection SDV
- Decitabine Intravenous Solution
- Capecitabine Tablets
- Lisdexamfetamine Capsules
- Lisdexamfetamine Chewable Tablets
- Lidocaine HCL Injection MDV
- Lidocaine HCL Injection SDV
- Dabigatran 110mg Capsules
- Diatrizoate Meglumine & Diatrizoate Sodium Solution
- Acetaminophen Intravenous Solution
- Ivabradine Tablets
- Eszopiclone Tablets
- Ezetimibe Tablets
- Gabapentin Oral Solution
- Pantoprazole PFOS
- Divalproex Sodium ER Tablets
- Pitavastatin Tablets
- Mesalamine DR Tablets
- Rufinamide Oral Suspension
- Levonorgestrel-Ethinyl Estradiol
- Allopurinol Tablets
- Aripiprazole Oral Solution
- Gabapentin Tablets
- Quetiapine Fumarate Tablets
- Fesoterodine ER Tablets
- Icosapent Ethyl Capsules
- Atorvastatin Tablets
- Varenicline Tablets
- Oxcarbazepine Oral Suspension
- Paliperidone ER Tablets